Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection…
A recent report revealed that, in the US, the rate of babies being born prematurely has been rising. Between 2014…
Molecular diagnostics company Genetic Technologies (ASX: GTG) is piloting its risk assessment test geneType in breast screening centres across the…
Aussie biosensor company Universal Biosensors (ASX: UBI) has received the US FDA 510(k) and CLIA Waiver approval for its Xprecia…
Australia’s labour shortage struggles are far from over, continuing to impact companies like diagnostic imaging services provider Integral Diagnostics (ASX:…
Aussie medical device company Atomo Diagnostics (ASX: AT1), which provides rapid diagnostic tests, witnessed strong growth in revenue and margins…